TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32238507

Group type: EXPERIMENTAL
Intervention: Telephone-based cognitive behavioral therapy (T-CBT)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 72
Study: 34858310

Group type: EXPERIMENTAL
Intervention: Unilateral tDCS
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Bilateral tDCS
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo tDCS (sham)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Training alone
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Combination of training and tDCS
Number of subjects: 40
Study: 34867115

Group type: EXPERIMENTAL
Intervention: Intelligent training system, twice a day, 20 minutes each time.
Number of subjects: 48

Group type: COMPARATOR
Intervention: Conventional rehabilitation training (control group).
Number of subjects: 48
Study: 33048906

Group type: EXPERIMENTAL
Intervention: Nurse-led consultations (3 sessions within 2 months)
Number of subjects: 224

Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 224
Study: 35872355

Group type: EXPERIMENTAL
Intervention: 15% HP + blue LED
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 15% HP + violet LED
Number of subjects: 30

Group type: COMPARATOR
Intervention: 35% HP
Number of subjects: 30
Study: 35857752

Group type: EXPERIMENTAL
Intervention: N-Acetylcysteine (NAC) 2 g daily
Number of subjects: 84
Study: 33899191

Group type: EXPERIMENTAL
Intervention: 3g of magnesium sulfate in 100mL of glucose solution (Group A)
Number of subjects: 103

Group type: COMPARATOR
Intervention: 100 mL of glucose solution (Group B)
Number of subjects: 103
Study: 35551291

Group type: EXPERIMENTAL
Intervention: PGDM1400, PGT121, and VRC07-523LS (20 mg kg−1 each)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: PGDM1400, PGT121, and VRC07-523LS
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: PGDM1400 and PGT121
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: VRC07-523LS
Number of subjects: 5
Study: 33309151

Group type: EXPERIMENTAL
Intervention: Interventions improving life-expectancy
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Interventions improving quality-of-life
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Interventions involving socioeconomic groups
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Interventions involving neutrally labelled groups
Number of subjects: 80
Study: 32074953

Group type: EXPERIMENTAL
Intervention: Endurance training (ET) - 3 times/week on a treadmill for 8 weeks
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Circuit resistance training (RT) - equal number of circuit weight training sessions for 8 weeks
Number of subjects: 57

Group type: COMPARATOR
Intervention: Non-exercising control group
Number of subjects: 57
Study: 35751528

Group type: EXPERIMENTAL
Intervention: Rivaroxaban 2.5 mg b.i.d. plus aspirin 100 mg o.d.
Number of subjects: 27495

Group type: COMPARATOR
Intervention: Aspirin 100 mg o.d.
Number of subjects: 27495
Study: 33029705

Group type: EXPERIMENTAL
Intervention: Folinic acid (2 mg/kg up to 50 mg per day)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study: 32911530

Group type: EXPERIMENTAL
Intervention: Plyometric exercises
Number of subjects: 23

Group type: COMPARATOR
Intervention: Strength exercises
Number of subjects: 23
Study: 35868342

Group type: EXPERIMENTAL
Intervention: Pay-it-forward intervention (free influenza vaccine and opportunity to donate)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Pay-it-forward intervention
Number of subjects: 300

Group type: COMPARATOR
Intervention: Standard-of-care user-paid vaccination
Number of subjects: 300
Study: 33814451

Group type: EXPERIMENTAL
Intervention: Go/No-Go task measuring commission errors (CE) and intraindividual variability of reaction time (CV) over a 90-second test.
Number of subjects: 110

Group type: COMPARATOR
Intervention: Go/No-Go task measuring commission errors (CE) and intraindividual variability of reaction time (CV).
Number of subjects: 110
Study: 35678327

Group type: EXPERIMENTAL
Intervention: Normoxia group (NG) with PaO2 between ≥100 and <180 mmHg and at least 40% FiO2 mechanical ventilation (MV)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Normoxia group (NG)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Hyperoxia group (HG) with PaO2 ≥180 mmHg and 100% FiO2 MV
Number of subjects: 100
Study: 33514604

Group type: EXPERIMENTAL
Intervention: Dry flocked swab (DF)
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Wet dacron swab (WD)
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Urine sample (Colli-Pee device)
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Qvintip (QT)
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: HerSwab (HS)
Number of subjects: 600
Study: 32933577

Group type: EXPERIMENTAL
Intervention: Enhanced support from a physiotherapist (PT group)
Number of subjects: 190

Group type: COMPARATOR
Intervention: Ordinary PAP treatment at the health care centre (HCC group)
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: PT group
Number of subjects: 190

Group type: COMPARATOR
Intervention: HCC group
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 190
Study: 35576638

Group type: COMPARATOR
Intervention: Control diet
Number of subjects: 540

Group type: EXPERIMENTAL
Intervention: 300 mg/kg magnolol (M300)
Number of subjects: 540

Group type: EXPERIMENTAL
Intervention: 300 mg/kg honokiol (H300)
Number of subjects: 540

Group type: EXPERIMENTAL
Intervention: 300 mg/kg total phenols with a magnolol/honokiol ratio of 2:1 (M200H100)
Number of subjects: 540

Group type: EXPERIMENTAL
Intervention: 300 mg/kg total phenols with a magnolol/honokiol ratio of 1:2 (M100H200)
Number of subjects: 540

Group type: EXPERIMENTAL
Intervention: 300 mg/kg total phenols with a magnolol/honokiol ratio of 1:1 (M150H150)
Number of subjects: 540
Study: 34704866

Group type: EXPERIMENTAL
Intervention: MindfulGarden (MG), a digital calming device, used during morning and evening care for 3 days, followed by exposure with verbal prompting on Day 4.
Number of subjects: 13

Group type: COMPARATOR
Intervention: Usual care only (control group).
Number of subjects: 13
Study: 32712801

Group type: EXPERIMENTAL
Intervention: Physical Activity (PA)
Number of subjects: 720

Group type: EXPERIMENTAL
Intervention: Healthy Food Intake Index (HFII)
Number of subjects: 720

Group type: EXPERIMENTAL
Intervention: Glycemic health
Number of subjects: 720

Group type: EXPERIMENTAL
Intervention: Physical Activity (PA) and Healthy Food Intake Index (HFII)
Number of subjects: 720
Study: 35111716

Group type: EXPERIMENTAL
Intervention: Olfactory priming
Number of subjects: 9811

Group type: EXPERIMENTAL
Intervention: Visual priming
Number of subjects: 9811

Group type: EXPERIMENTAL
Intervention: Both olfactory and visual priming
Number of subjects: 9811

Group type: COMPARATOR
Intervention: Control
Number of subjects: 9811
Study: 35845514

Group type: EXPERIMENTAL
Intervention: 0.1 mg/kg esketamine, i.v.
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: 0.2 mg/kg esketamine, i.v.
Number of subjects: 120

Group type: COMPARATOR
Intervention: Regular anesthesia model (Group A, control)
Number of subjects: 120
Study: 33420781

Group type: EXPERIMENTAL
Intervention: Safety guidewire present (Group 1)
Number of subjects: 320

Group type: COMPARATOR
Intervention: No safety guidewire (Group 2)
Number of subjects: 320
Study: 33687286

Group type: EXPERIMENTAL
Intervention: Nonsurgical treatment
Number of subjects: 119

Group type: COMPARATOR
Intervention: Surgical treatment
Number of subjects: 119
Study: 36355638

Group type: EXPERIMENTAL
Intervention: ACTS2 lay pastoral care facilitator‐led, telephone cognitive‐behavioral intervention
Number of subjects: 9
Study: 34126044

Group type: EXPERIMENTAL
Intervention: Stereotactic body radiotherapy at a dose of 24 Gy in two daily fractions
Number of subjects: 229

Group type: COMPARATOR
Intervention: Conventional external beam radiotherapy at a dose of 20 Gy in five daily fractions
Number of subjects: 229

Group type: EXPERIMENTAL
Intervention: Stereotactic body radiotherapy
Number of subjects: 229

Group type: COMPARATOR
Intervention: Conventional external beam radiotherapy
Number of subjects: 229
Study: 32717684

Group type: EXPERIMENTAL
Intervention: Fingolimod
Number of subjects: 875

Group type: COMPARATOR
Intervention: iDMT
Number of subjects: 875
Study: 37133765

Group type: EXPERIMENTAL
Intervention: Ileal conduit (IC)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Single stoma uretero-cutanoustomy (SSUC)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Functional Assessment of Cancer Therapy‐Bladder Cancer (FACT‐BL)
Number of subjects: 100
Study: 33620008

Group type: EXPERIMENTAL
Intervention: LAA-loaded spanlastics
Number of subjects: 0

Group type: COMPARATOR
Intervention: Topical LAA solution
Number of subjects: 0

Group type: COMPARATOR
Intervention: UVB treatment
Number of subjects: 0
Study: 32377672

Group type: EXPERIMENTAL
Intervention: General Practice Pharmacist (GPP) intervention
Number of subjects: 23
Study: 35609943

Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Number of subjects: 102

Group type: COMPARATOR
Intervention: Control (standard therapy)
Number of subjects: 102
Study: 33825213

Group type: EXPERIMENTAL
Intervention: Behavioural Sleep Intervention (BSI)
Number of subjects: 82
Study: 32513273

Group type: EXPERIMENTAL
Intervention: TTM-based exercise program (24 weeks)
Number of subjects: 189

Group type: EXPERIMENTAL
Intervention: TTM-based exercise program
Number of subjects: 189

Group type: COMPARATOR
Intervention: Control group (same-length exercise program guidance without adherence interventions)
Number of subjects: 189
Study: 33710166

Group type: EXPERIMENTAL
Intervention: Light therapy for 12 weeks
Number of subjects: 24
Study: 33379181

Group type: EXPERIMENTAL
Intervention: Enriched protein drink (whey protein enriched with leucine and vitamin D)
Number of subjects: 123

Group type: COMPARATOR
Intervention: Isocaloric control
Number of subjects: 123
Study: 34580995

Group type: EXPERIMENTAL
Intervention: Finerenone
Number of subjects: 5674
Study: 33719782

Group type: EXPERIMENTAL
Intervention: Brexanolone injection
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Clinical response (≥50% reduction in HAMD-17 total score)
Number of subjects: 127

Group type: COMPARATOR
Intervention: Baseline HRQoL
Number of subjects: 127
Study: 32839221

Group type: COMPARATOR
Intervention: RO7049389 (single dose of 150 to 2,500 mg)
Number of subjects: 83

Group type: COMPARATOR
Intervention: RO7049389 (multiple doses of 200 to 800 mg)
Number of subjects: 83

Group type: COMPARATOR
Intervention: RO7049389 (450 mg) under fasted and fed conditions
Number of subjects: 83

Group type: COMPARATOR
Intervention: RO7049389
Number of subjects: 83

Group type: COMPARATOR
Intervention: RO7049389 (up to a single dose of 2,500 mg)
Number of subjects: 83
Study: 35774427

Group type: EXPERIMENTAL
Intervention: Darbepoetin alfa
Number of subjects: 466

Group type: COMPARATOR
Intervention: Epoetin alfa
Number of subjects: 466
Study: 34284936

Group type: EXPERIMENTAL
Intervention: Mobilization on the day of surgery (day 0 group)
Number of subjects: 167

Group type: COMPARATOR
Intervention: Mobilization the day after surgery (day 1 group)
Number of subjects: 167
Study: 34648192

Group type: EXPERIMENTAL
Intervention: Fluconazole (CYP2C19 inhibitor)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin (CYP1A2 inhibitor)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin/Fluconazole (combination)
Number of subjects: 12
Study: 32753063

Group type: EXPERIMENTAL
Intervention: Paracetamol 1g
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Paracetamol-diclofenac (1g + 75mg)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Paracetamol-tramadol (1g + 100mg)
Number of subjects: 63
Study: 35851187

Group type: EXPERIMENTAL
Intervention: Hydrodissection (HD) of the retroprostatic space (RPS) during nsRALP
Number of subjects: 25

Group type: COMPARATOR
Intervention: Standard nsRALP without HD
Number of subjects: 25
Study: 34565001

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine combined with flurbiprofen axetil (D & F Group)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Flurbiprofen axetil (F Group)
Number of subjects: 60
Study: 36858151

Group type: EXPERIMENTAL
Intervention: Apalutamide (240 mg/day) plus ADT
Number of subjects: 1052

Group type: COMPARATOR
Intervention: Placebo plus ADT
Number of subjects: 1052
Study: 34474135

Group type: EXPERIMENTAL
Intervention: Deltopectoral approach (group I)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Anterosuperior approach (group II)
Number of subjects: 98
Study: 32712347

Group type: EXPERIMENTAL
Intervention: Deoxymyoglobin (DeOxy; packaged within 3 min)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Oxygenation (Oxy; oxygenated in air for 30 min)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: High oxygenation (HiOxy; packaged for 24 h in 80% O2)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: HiOxy steaks frozen for under 6 months
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: HiOxy steaks with extended frozen storage and RD
Number of subjects: 36
Study: 33400012

Group type: EXPERIMENTAL
Intervention: High-Intensity Laser Therapy (HILT) + exercise
Number of subjects: 63

Group type: COMPARATOR
Intervention: Sham HILT + exercise
Number of subjects: 63
Study: 34968932

Group type: EXPERIMENTAL
Intervention: Online game-based learning with the watch-summarize-question strategy
Number of subjects: 45

Group type: COMPARATOR
Intervention: Video-based learning (Control)
Number of subjects: 45
Study: 34939432

Group type: EXPERIMENTAL
Intervention: Nomogram for predicting cancer-specific survival (CSS)
Number of subjects: 1144
Study: 34911731

Group type: EXPERIMENTAL
Intervention: AKI-SCAMP
Number of subjects: 224
Study: 33027400

Group type: EXPERIMENTAL
Intervention: Breastfeeding Educational Kit (KEAM)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 104
Study: 35965421

Group type: EXPERIMENTAL
Intervention: Propolis (300 mg)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Metformin (850 mg)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 34706709

Group type: EXPERIMENTAL
Intervention: Self-managed TTNS at home
Number of subjects: 16

Group type: COMPARATOR
Intervention: HCP-led TTNS in hospital clinic
Number of subjects: 16
Study: 35906663

Group type: EXPERIMENTAL
Intervention: Anti-stigma campaign co-created by adolescents and a mobile technology-based electronic decision support system
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (not explicitly defined in the abstract)
Number of subjects: 30
Study: 34870118

Group type: EXPERIMENTAL
Intervention: Exercising in shallow water
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Exercising in deep water
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (no exercise)
Number of subjects: 36
Study: 35604013

Group type: EXPERIMENTAL
Intervention: Laparoscopic suturing by experts (LSE)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Laparoscopic suturing by novices (LSN)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Aggregate performance score for experts (LSE)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Aggregate performance score for novices (LSN)
Number of subjects: 16
Study: 33252432

Group type: EXPERIMENTAL
Intervention: Preconsultation Educational Group Intervention (PEGI)
Number of subjects: 156

Group type: COMPARATOR
Intervention: Routine education
Number of subjects: 156
Study: 33326371

Group type: EXPERIMENTAL
Intervention: Prenatal vitamin D supplementation (2 oral doses of 50,000 IU)
Number of subjects: 283

Group type: COMPARATOR
Intervention: Control group (routine prenatal care)
Number of subjects: 283

Group type: EXPERIMENTAL
Intervention: Vitamin D levels (25(OH)D)
Number of subjects: 283
Study: 36167565

Group type: EXPERIMENTAL
Intervention: Disease-centred advance directive
Number of subjects: 15

Group type: COMPARATOR
Intervention: Common advance directive
Number of subjects: 15
Study: 33581259

Group type: EXPERIMENTAL
Intervention: Palonosetron 0.25mg
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Palonosetron 0.5mg
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Palonosetron 0.75mg
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Palonosetron (all doses)
Number of subjects: 18
Study: 35932359

Group type: EXPERIMENTAL
Intervention: Peer-driven intervention
Number of subjects: 385

Group type: COMPARATOR
Intervention: Control networks (HIV testing and counseling)
Number of subjects: 385
Study: 32539224

Group type: EXPERIMENTAL
Intervention: Dapagliflozin 10 mg
Number of subjects: 4744

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4744
Study: 32265083

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine infusion (0.7 μg/kg/h in the operating room and 0.4 μg/kg/h in the ICU)
Number of subjects: 169

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine infusion
Number of subjects: 169

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine administration
Number of subjects: 169
Study: 32974838

Group type: EXPERIMENTAL
Intervention: damoctocog alfa pegol
Number of subjects: 18

Group type: COMPARATOR
Intervention: rurioctocog alfa pegol
Number of subjects: 18
Study: 35994795

Group type: EXPERIMENTAL
Intervention: Aromatherapy through the skin and by inhalation
Number of subjects: 70

Group type: COMPARATOR
Intervention: Routine nursing care (Control)
Number of subjects: 70
Study: 34516363

Group type: EXPERIMENTAL
Intervention: Brazil nut supplementation (1 Brazil nut/day for 3 months)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 36
Study: 35805060

Group type: EXPERIMENTAL
Intervention: Geriatric Assessment (GA)‐driven interventions and follow‐up for 24 months
Number of subjects: 499

Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 499
Study: 35022796

Group type: EXPERIMENTAL
Intervention: JUUL e‐cigarettes for 6 weeks
Number of subjects: 114
Study: 32516811

Group type: EXPERIMENTAL
Intervention: Closed wound drain (Redon)
Number of subjects: 800

Group type: COMPARATOR
Intervention: No drain (Control)
Number of subjects: 800
Study: 34304467

Group type: EXPERIMENTAL
Intervention: Tympanic tympanoplasty under otoendoscope (study group)
Number of subjects: 176

Group type: COMPARATOR
Intervention: Intratympanic injection of methylprednisolone (control group)
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 176
Study: 32629078

Group type: EXPERIMENTAL
Intervention: Dose-escalated arm (up to 95 Gy prescribed to the tumor)
Number of subjects: 539

Group type: EXPERIMENTAL
Intervention: Replanning of 21 plans
Number of subjects: 539

Group type: EXPERIMENTAL
Intervention: Prediction model for tumor D98%
Number of subjects: 539

Group type: COMPARATOR
Intervention: Both arms (dose constraints to organs at risk)
Number of subjects: 539
Study: 36435230

Group type: EXPERIMENTAL
Intervention: Teacher-designed games (TDG)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Child-designed games (CDG)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Both groups (TDG and CDG)
Number of subjects: 30
Study: 32935315

Group type: EXPERIMENTAL
Intervention: Higher-knowledge physicians
Number of subjects: 62

Group type: COMPARATOR
Intervention: Lower-knowledge physicians
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 62
Study: 32911776

Group type: EXPERIMENTAL
Intervention: Messages about the environment’s influence on obesity (Study 1 & 2)
Number of subjects: 4391

Group type: EXPERIMENTAL
Intervention: Messages about the environment’s influence on human behaviour (Study 1)
Number of subjects: 4391

Group type: COMPARATOR
Intervention: No message (Control group)
Number of subjects: 4391
Study: 36125170

Group type: EXPERIMENTAL
Intervention: Advertisement for a hypothetical cold sore medicine
Number of subjects: 1295

Group type: COMPARATOR
Intervention: Control group (no advertisement)
Number of subjects: 1295
Study: 33811685

Group type: EXPERIMENTAL
Intervention: Pentraxin-3 (PTX3) detected in saliva
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Pentraxin-3 (PTX3)
Number of subjects: 106
Study: 32929897

Group type: EXPERIMENTAL
Intervention: AIHIP system (trial group)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Acetate templating (control group)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Trial group
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study: 35840918

Group type: EXPERIMENTAL
Intervention: Orem-based self-care education (five 60-minute sessions, one session per week)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 100
Study: 34240443

Group type: EXPERIMENTAL
Intervention: Constrained Lasso approach with hierarchical interaction restriction
Number of subjects: 2569

Group type: COMPARATOR
Intervention: Unstructured Lasso
Number of subjects: 2569
Study: 32748303

Group type: EXPERIMENTAL
Intervention: Multi-component upper-extremity intervention
Number of subjects: 73
Study: 34674922

Group type: EXPERIMENTAL
Intervention: Mobile app for teaching communication skills about diagnostic uncertainty
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Mobile app use
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Senior residents
Number of subjects: 109
Study: 34537448

Group type: EXPERIMENTAL
Intervention: Bronchoscopic airway clearance therapy (B-ACT)
Number of subjects: 189

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 189
Study: 35066509

Group type: EXPERIMENTAL
Intervention: Esmolol
Number of subjects: 40

Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 40
Study: 33228480

Group type: EXPERIMENTAL
Intervention: max t‐test‐type statistics (multiple contrast tests)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: randomization‐based approach
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: simulation studies
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: real data set
Number of subjects: 0
Study: 35811511

Group type: EXPERIMENTAL
Intervention: Compression stocking A (interface pressure 18-20 mmHg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Compression stocking B (interface pressure 18-20 mmHg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Below-knee low-pressure support stocking (LPSS) (interface pressure 8-10 mmHg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Compression stockings A and B compared to LPSS
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: All three types of stockings
Number of subjects: 0
Study: 36138504

Group type: EXPERIMENTAL
Intervention: Guided Pelvic Floor Exercises
Number of subjects: 62

Group type: COMPARATOR
Intervention: Written information (control group)
Number of subjects: 62